Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Hay

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Systematic Reviews|January 18, 2023
Identifying effect modifiers of CAR-T cell therapeutic efficacy: a systematic review and individual patient data meta-analysis protocolManoj M Lalu, Natasha Kekre, Joshua Montroy, et al.
British Journal of Haematology|July 21, 2020
Building Canadian capacity for CAR-T cells in relapsed/refractory acute lymphoblastic leukaemia: a retrospective cohort studyRoy Khalife, Joshua Montroy, Emma J M Grigor, et al.
British Journal of Haematology|June 26, 2020
Amelioration of COVID-19-related cytokine storm syndrome: parallels to chimeric antigen receptor-T cell cytokine release syndromeRyan L Hoiland, Sophie Stukas, Jennifer Cooper, et al.
Transfusion Medicine Reviews|April 25, 2025
Identifying Modifiers of CAR T-Cell Therapeutic Efficacy and Safety: A Systematic Review and Individual Patient Data Meta-AnalysisManoj M Lalu, Samuel Igweokpala, Natasha Kekre, et al.
Current Oncology (Toronto, Ont.)|February 26, 2026
Real-World Outcomes of Axicabtagene Ciloleucel for Treatment of Relapsed or Refractory Large B-Cell Lymphoma in CanadaChristopher Lemieux, John Kuruvilla, Mona Shafey, et al.
Acta Haematologica|August 28, 2024
Real-World Impact of Routine Addition of Antithymocyte Globulin to Standard GVHD Prophylaxis in Myeloablative Unrelated Donor Transplants: Important Gains in Graft-versus-Host Disease Prevention though No Difference in Overall SurvivalNi Bai, Wasithep Limvorapitak, Robert Henderson, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 29, 2025
Salvage Autologous Stem Cell Transplantation Outcomes and The Use of Maintenance in Relapsed Multiple Myeloma: Real world evidence from the Canadian Myeloma Research Group DatabaseRayan Kaedbey, Christopher P Venner, Donna Reece, et al.
Nature Cancer|July 1, 2026
GPNMB-directed CAR T cell therapy against MiT/TFE-family fusion-driven solid tumorsFranz J Zemp, Zackariah Breckenridge, Hyojin Song, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Systematic Reviews|January 18, 2023
Identifying effect modifiers of CAR-T cell therapeutic efficacy: a systematic review and individual patient data meta-analysis protocolManoj M Lalu, Natasha Kekre, Joshua Montroy, et al.
British Journal of Haematology|July 21, 2020
Building Canadian capacity for CAR-T cells in relapsed/refractory acute lymphoblastic leukaemia: a retrospective cohort studyRoy Khalife, Joshua Montroy, Emma J M Grigor, et al.
British Journal of Haematology|June 26, 2020
Amelioration of COVID-19-related cytokine storm syndrome: parallels to chimeric antigen receptor-T cell cytokine release syndromeRyan L Hoiland, Sophie Stukas, Jennifer Cooper, et al.
Transfusion Medicine Reviews|April 25, 2025
Identifying Modifiers of CAR T-Cell Therapeutic Efficacy and Safety: A Systematic Review and Individual Patient Data Meta-AnalysisManoj M Lalu, Samuel Igweokpala, Natasha Kekre, et al.
Current Oncology (Toronto, Ont.)|February 26, 2026
Real-World Outcomes of Axicabtagene Ciloleucel for Treatment of Relapsed or Refractory Large B-Cell Lymphoma in CanadaChristopher Lemieux, John Kuruvilla, Mona Shafey, et al.
Acta Haematologica|August 28, 2024
Real-World Impact of Routine Addition of Antithymocyte Globulin to Standard GVHD Prophylaxis in Myeloablative Unrelated Donor Transplants: Important Gains in Graft-versus-Host Disease Prevention though No Difference in Overall SurvivalNi Bai, Wasithep Limvorapitak, Robert Henderson, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 29, 2025
Salvage Autologous Stem Cell Transplantation Outcomes and The Use of Maintenance in Relapsed Multiple Myeloma: Real world evidence from the Canadian Myeloma Research Group DatabaseRayan Kaedbey, Christopher P Venner, Donna Reece, et al.
Nature Cancer|July 1, 2026
GPNMB-directed CAR T cell therapy against MiT/TFE-family fusion-driven solid tumorsFranz J Zemp, Zackariah Breckenridge, Hyojin Song, et al.
Pageof 2